论文部分内容阅读
作者给7例妇女于月经后立即放置释放 ST—1435的宫颈内避孕器(ST-ICD),观察10个月。对其出血类型、临床表现及其对垂体和卵巢功能的影响做了评价。 ST-1435是一种新型孕激素(16-亚甲基17a乙酰氧基-19去甲基-4孕烯-3.20二酮)。肠外避孕有效,口服无效。该避孕器自短水平臂的 Nova-T 发展而来。硅橡胶棒中填满 ST-1435(类固醇重量占50%),外面包覆硅橡胶管,并固定于到避孕器的纵臂上。水平臂全长14mm。当妇女月经干净后立即放入ST-ICD,最晚也不得超过周期的第七天。记录出血和副作用。参加本研究妇女,在试验前三
The authors placed 7 cases of women with ST-ICD releasing ST-1435 immediately after menstruation for 10 months. The type of bleeding, clinical manifestations and its impact on pituitary and ovarian function were evaluated. ST-1435 is a novel progestin (16-methylene 17a acetoxy-19 desmethyl-4 pregnane-3.12 dione). Extraintestinal contraception is effective, oral ineffective. The contraceptives developed from Nova-T, a short horizontal arm. The silicone wand is filled with ST-1435 (steroid weight 50%), covered with a silicone rubber tube and secured to the trailing arm of the device. Horizontal arm length 14mm. When the woman’s menstrual clean immediately into the ST-ICD, no later than the seventh day of the cycle. Record bleeding and side effects. Women participating in this study, the first three in the trial